Manufacturing of Occlusive Chest Wound Seal Dressings

The contract calls for the manufacturing of specialized occlusive chest wound seal dressings designed for military medical applications, requiring the product to be latex-free and composed of a hydrophilic gel adhesive that remains translucent to allow for wound monitoring. The dressings must maintain a 36-month shelf life under standard storage conditions and be packaged in resealable containers to ensure sterility and usability across multiple applications. The technical specifications emphasize reliability, durability, and compatibility with field conditions, ensuring rapid deployment and effectiveness in trauma scenarios. Production must comply with stringent medical device standards to meet the operational demands of deployed personnel. The solicitation is issued as a subcontract under the Department of Defense’s Medical Supply Chain, with the place of performance designated as Fort Bragg, North Carolina, 28310. The opportunity was posted on July 26, 2026, with responses due by August 3, 2026, under NAICS code 325120, which pertains to pharmaceutical and medicine manufacturing. The procurement is part of an ongoing effort to modernize and standardize battlefield medical equipment, and qualified vendors must demonstrate proven capacity in producing Class II medical devices with consistent quality control, regulatory compliance, and scalable production capabilities to fulfill military requirements without interruption.